Claim Missing Document
Check
Articles

Found 2 Documents
Search

Pengembangan Bank Sampah Dahlia melalui Digitalisasi Manajemen Saleha, Eha; Safitri, Julia; Rahayu, Sri; Hidayat, Rahmat; Hutasoit, Erikson; Pamungkas, Pamungkas
Sinergi Abdimas Jurnal Pengabdian Masyarakat Vol 2 No 2 (2023): Sinergi Abdimas Jurnal Pengabdian Masyarakat
Publisher : Fakultas Ekonomi & Bisnis Universitas Jenderal Soedirman

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32424/siabdi.v2i2.10888

Abstract

Bank Sampah Dahlia merupakan salah satu organisasi kelompok sosial masyarakat yang bergerak di bidang ekonomi lingkungan khususnya dalam pengelolaan sampah rumah tangga warga RW 01 Petukangan Selatan, Pesanggarahan – Jakarta Selatan. Saat ini Bank Sampah Dahlia memiliki 13 orang pengurus yang diketuai oleh ibu Aliyah. Keberadaan Bank Sampah Dahlia di lingkungan RW 01 Petukangan Selatan sangat membantu pemerintah kota Jakarta Selatan dalam pengurangan penumpukan sampah ke Tempat Pemrosesan Akhir (TPA) dan membantu meningkatkan perekonomian ibu-ibu rumah tangga karena memberikan wadah untuk mendaur ulang sampah dengam metode 3R (Reuse, Reduce Recycle). Permasalahan yang dihadapi Bank Sampah Dahlia: 1) Pengurus Bank Sampah didominasi lansia (diatas 50 tahun), sehingga pelaksanaan program kegiatan kurang efektif dan efisien, 2) Pencatatan transaksi masih di lakukan secara manual karena belum terkomputerisasi, sehingga seringkali terjadi kesalahan dalam pencatatan dan pelaporan keuangan, 3) sampah organik dan anorganik belum dikelola dan dipasarkan secara maksimal. Berdasarkan permasalahan diatas, maka program kemitraan masyarakat ini memberikan solusi dengan cara: 1) Pelatihan kaderisasi dan edukasi terkait pengelolaan sampah yang efektif dan efisien, 2) Pembuatan sistem informasi manajemen Bank Sampah berbasis WEB dan Mobile Application. 3) Pelatihan pemasaran produk daur ulang sampah secara online.
Antiviral treatment of COVID-19 Andina, Andina; Sugiarto, Sugiarto; Pamungkas, Pamungkas
The International Journal of Medical Science and Health Research Vol. 5 No. 6 (2024): The International Journal of Medical Science and Health Research
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/3kv7z420

Abstract

Background: The literature on antiviral treatments for COVID-19 reflects a rapidly evolving field, characterized by a diversity of therapeutic strategies and ongoing clinical investigations. The collaborative efforts of various institutions have been pivotal in identifying effective treatment options, as evidenced by the RECOVERY trial's findings on dexamethasone and remdesivir's efficacy (Sarkar et al., 2020). The urgency for effective treatments is underscored by the ongoing transmission of the virus and the emergence of new variants, necessitating a comprehensive evaluation of available antiviral agents. Literature Review: Favipiravir has emerged as a significant candidate for treating mild to moderate COVID-19 cases, with systematic reviews and meta-analyses indicating its clinical efficacy (Hassanipour et al., 2021). The comparative analysis of favipiravir and remdesivir highlights their mechanisms of action, reinforcing the need for continued exploration of these and other antiviral options (Andrei Negru et al., 2022). Furthermore, molnupiravir has gained attention for its promising pharmacokinetics and clinical trial results, demonstrating its potential in the antiviral arsenal against COVID-19 (Khiali et al., 2022). The landscape of antiviral therapies is further enriched by a comprehensive review of small-molecular therapeutics, emphasizing the need for novel strategies to address the challenges posed by emerging variants (Zhong et al., 2022). The repurposing of established drugs with known safety profiles remains a critical area of focus, as highlighted by the analysis of various antiviral agents, including remdesivir and favipiravir (Sahin et al., 2022).. Conclusion: In conclusion, the body of literature reflects significant advancements in the antiviral treatment of COVID-19 while highlighting the complexities and challenges that remain. The continuous evaluation and adaptation of therapeutic strategies are essential to effectively combat the evolving landscape of COVID-19 and its associated variants.